Literature DB >> 10849536

Cunninghamella infection post bone marrow transplant: case report and review of the literature.

L Darrisaw1, G Hanson, D H Vesole, S C Kehl.   

Abstract

Cunninghamella spp., in the class Zygomycete and order Mucorales, are unusual opportunistic pathogens that have been identified with increased frequency in immunocompromised patients. Infections with this group of organisms have been seen most frequently in patients with hematologic malignancy. We describe an allogeneic bone marrow recipient who developed fungal pneumonitis and disseminated fungal dermatitis caused by Cunninghamella spp. To our knowledge, this is the first reported case of Cunninghamella infection in a BMT recipient. The case highlights the mortality associated with opportunistic infections in immunocompromised patients and confirms the risk factors associated with non-candida fungal infections after bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849536     DOI: 10.1038/sj.bmt.1702395

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.

Authors:  Chao Luo; Jiasheng Wang; Yongxian Hu; Yi Luo; Yamin Tan; Aiyun Jin; Bin Wei; Huixian Hu; He Huang
Journal:  Mycopathologia       Date:  2016-06-28       Impact factor: 2.574

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Nosocomial invasive infection caused by Cunninghamella bertholletiae: case report.

Authors:  Xisto Sena Passos; Werther Souza Sales; Patrícia Jackeline Maciel; Carolina Rodrigues Costa; Denise Milioli Ferreira; Maria Rosário Rodrigues do Silva
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

4.  Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Authors:  Miki Kasai; Susan M Harrington; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Mara G Beveridge; Tena Knudsen; Jeffery Milanovich; Margaret P Cotton; Johanna Hughes; Robert L Schaufele; Tin Sein; John Bacher; Patrick R Murray; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

Review 5.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

6.  Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Authors:  Hikari Ota; Hisashi Yamamoto; Muneyoshi Kimura; Hideki Araoka; Takeshi Fujii; Takashi Umeyama; Hideaki Ohno; Yoshitsugu Miyazaki; Daisuke Kaji; Yuki Taya; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Mycopathologia       Date:  2017-06-02       Impact factor: 2.574

Review 7.  COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis.

Authors:  Rachel Samson; Mahesh Dharne
Journal:  3 Biotech       Date:  2021-12-06       Impact factor: 2.893

8.  Successful treatment of invasive fungal rhinosinusitis caused by Cunninghamella: A case report and review of the literature.

Authors:  Yong-Cai Liu; Min-Li Zhou; Ke-Jia Cheng; Shui-Hong Zhou; Xue Wen; Cheng-Dong Chang
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.